Skip to main content

AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise.  The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).

Learn more about the comment process

AMIA responses are arranged by Federal Agency and Congressional Committee.

Showing 11 - 20 out of 52

AMIA Applauds PI Program Flexibilities for Hospitals, Reiterates Support for Activity-Based Approach to Demonstrating Health IT Use

June 26, 2019

In comments submitted to the Centers for Medicare & Medicaid Services (CMS), the American Medical Informatics Association (AMIA) supported proposed flexibilities in how hospitals comply with the Promoting Interoperability (PI) Program and those that incentivize them to continue investments in health IT. However, they continued to urge CMS to more […]

AMIA Supports, Encourages Further Refinement of FDA AI/Machine Learning Regulatory Framework

June 5, 2019

In comments submitted this week to the U.S. Food and Drug Administration (FDA), the nation’s informatics professionals applauded the agency for developing a regulatory Modification Framework for Artificial Intelligence (AI)/Machine Learning (ML)-based software as a medical device (SaMD). The American Medical Informatics Association (AMIA) offered additional observations and recommendations for […]

AMIA Weighs-In on NIST Remote Patient Monitoring Project

December 21, 2018

In response to a Request for Information from the National Institute for Standards and Technology, AMIA recommended that a planned project to develop a reference architecture for remote patient monitoring utilize existing mobile infrastructures and available health IT standards, such as FHIR, to improve the likelihood of success.

AMIA Supports National Testing Collaborative for Health IT

December 20, 2018

In response to a Request for Information from the Centers for Disease Control and Prevention, AMIA urged HHS officials to focus on narrow use cases, such as CDS or eCQMs, when conceptualizing a national collaborative for health IT testing. AMIA also outlined the pros/cons of focusing on CDS versus eCQMs […]

AMIA Provides FDA Lit Review on Risk and Benefits of Medical Software

June 28, 2018

AMIA responded to an FDA request for input with a preliminary review of relevant research into the specific benefits and risks to health associated with software functions that the 21st Century Cures Act excluded from the definition of medical device. While some health IT applications to healthcare delivery have unambiguously […]